All short-listed abstracts (oral communications and posters) can be seen on the touchCARDIO website and featured in the 'European Journal of Arrhythmia & Electrophysiology' e-journal.
1.
ECG PREDICTORS OF THE EFFICACY OF HIS BUNDLE PACING IN PATIENTS WITH A PROLONGED PR INTERVAL: A STRATIFIED ANALYSIS OF THE HOPE-HF RANDOMISED CONTROLLED TRIAL - NANDITA KAZA, LONDON, UK |
2.
PERFORMANCE OF AN ARTIFICIAL INTELLIGENCE-POWERED SMARTPHONE APPLICATION IN THE UNITED KINGDOM CLINICAL SETTINGS: ECG AUTOMATION COMPARED TO HEALTHCARE PROFESSIONALS - AHMED KASSEM, CANTERBURY, UK |
3.
A FEDERATED DATA ANALYTIC AND META-MACHINE LEARNING APPROACH TO PREDICT INCIDENT ATRIAL FIBRILLATION IN PATIENTS WITH ACUTE STROKE: FIND-AF STROKE - RAMESH NADARAJAH, LEEDS, UK |
4.
ARTIFICIAL INTELLIGENCE-ENHANCED ELECTROCARDIOGRAPHIC IMAGES FOR MORTALITY AND FUTURE ATRIAL FIBRILLATION PREDICTION - BOROUMAND ZEIDAABADI, LONDON, UK |
5.
SEX DIFFERENCES IN ELECTROPHYSIOLOGY AND ANATOMY IMPROVES IN-SILICO DRUG TESTING IN ELECTROMECHANICAL MODELS OF HUMAN VENTRICLES - MAXX HOLMES, OXFORD, UK |
6.
IMPLANTABLE CARDIOVERTER DEFIBRILLATION IN PAEDIATRIC PATIENTS_ GREAT ORMOND STREET HOSPITAL EXPERIENCE - NAIF ALQWEAI, LONDON, UK |
7.
A PHYSIOLOGIST-LED SERVICE MANAGING CHANNELOPATHY PATIENTS WITH CARDIAC IMPLANTABLE ELECTRONIC DEVICES - LUCY MOORE, MANCHESTER, UK |
8.
SINGLE CENTRE EXPERIENCE OF EXTRAVASCULAR IMPLANTABLE CARDIOVERTER DEFIBRILLATORS: FROM PIVOTAL TO COMMERCIAL - PARISHA KHAN, LONDON, UK |
9.
SNAPSHOT REVIEW OF BIVENTRICULAR PACING BURDENS ACROSS OUR TRUST. HOW MANY OF OUR PATIENTS RECEIVE A ≥98% CARDIAC RESYNCHRONISATION THERAPY? - ADAM SIMPSON, MANCHESTER, UK |
10.
EVALUATING MODERN CARDIAC RESYNCHRONISATION THERAPY; WHAT ARE THE RESPONSE RATES AND HOW DO THEY COMPARE TO THE RANDOMISED CONTROLLED TRIALS? - EMMA BURTON, MIDDLESBROUGH, UK |
11.
INVESTIGATING NHS SERVICE PROVISION FOR PATIENTS WITH POSTURAL TACHYCARDIA SYNDROME IN THE UK WITH A VIEW TO IMPROVING UNDERSTANDING ACCESS AND OUTCOMES FOR PATIENTS - PHILIPPA TURNER, BIRMINGHAM, UK |
Oral Abstracts 1 - Arrhythmia Clinical
12.
ATRIAL FIBRILLATION VIRTUAL WARD: EFFECTIVE ARRHYTHMIA CARE BUT LIMITED DEMAND - JOSEPHINE MANSELL, LONDON, UK |
13.
USE OF AN AMBULATORY ECG PATCH AS AN ALTERNATIVE TO TRADITIONAL HOLTER MONITORING IN THE INITIAL INVESTIGATION OF ARRHYTHMIA - A DGH EXPERIENCE - RENY MATHAI, CHICHESTER, UK |
14.
PULSED FIELD ABLATION FOR THE TREATMENT OF ATRIAL FIBRILLATION IN PATIENTS WITH HEART FAILURE - OUTCOMES AND BENEFITS COMPARED TO RADIOFREQUENCY ABLATION - OMAR AHMED, LONDON, UK |
15.
REAL WORLD OUTCOMES FOR ATRIAL FIBRILLATION ABLATION IN PATIENTS WITH BMI OVER 30 - ARE NHS ENGLAND COMMISSIONING GUIDELINES APPROPRIATE? - THOMAS SLATER, LEEDS, UK |
16.
THE EFFECTIVENESS OF THORACOSCOPIC TREATMENT OF PERSISTENT AND LONG-TERM PERSISTENT FORMS OF ATRIAL FIBRILLATION DURING A THREE-YEAR FOLLOW-UP PERIOD - ELIZAVETA STREBKOVA, MOSCOW, RU |
Oral Abstracts 2 - Highest Scoring Abstracts
17.
IMPACT OF EMERGENT VS DELAYED VT ABLATION ON HEALTHCARE UTILISATION AND PHARMACOLOGICAL COST: A SUB-STUDY OF VITALITY - SHARON MAN, LEICESTER, UK |
18.
CLINICAL FINDINGS FROM A LARGE ENDO-EPICARDIAL ATRIAL ARRHYTHMIA ABLATION REGISTRY - KARTHICK MANOHARAN, BRIGHTON, UK |
19.
EARLY SINGLE CENTRE EXPERIENCE ADOPTING A VEIN OF MARSHALL ETHANOL ABLATION PROGRAMME - ALI NAJM, LIVERPOOL, UK |
20.
SYNCHRONOUS PACING WITH LEADLESS PACEMAKERS. A CASE SERIES ANALYSIS USING THE SYNCHROMAX SYSTEM - DIEGO EGAS, ECUADOR, US |
21.
POSITIVE STRUCTURAL AND FUNCTIONAL REMODELLING FOLLOWING CONVERGENT HYBRID ABLATION AND ENDOCARDIAL CATHETER ABLATION FOR PERSISTENT ATRIAL FIBRILLATION - A PROSPECTIVE BLINDED STUDY - OMAR AHMED, LONDON, UK |
22.
ARRHYTHMIC RISK STRATIFICATION IN NON-ISCHEMIC CARDIOMYOPATHY USING CARDIOVASCULAR MAGNETIC RESONANCE - ABBASIN ZEGARD, BIRMINGHAM, UK |
Oral Abstracts 2 - Arrhythmia Mechanisms / in silico tools
23.
{WITHDRAWN} AI TRIAGE PILOT: ENHANCING ECG ANALYSIS IN PRIMARY CARE - MUHAMMAD MURAD KHAN, LEEDS, UK |
24.
A COMPARISON OF OUTCOMES AFTER PULMONARY VEIN ISOLATION IN PATIENTS WITH ATRIAL FIBRILLATION AND LEFT ATRIAL DILATATION WHO UNDERGO REMODELLING AFTER CARDIOVERSION AGAINST THOSE WITH NORMAL LEFT ATRIAL DIMENSIONS - PRABESH KIRAT RAI, PLYMOUTH, UK |
25.
CORRELATION BETWEEN GAP JUNCTION REMODELLING AND THE CONTACT ELECTROGRAM IN HUMAN HEARTS - SHENGZHE LI, LONDON, UK |
26.
EVALUATING PERSONALISED HEART DIGITAL TWINS IN PREDICTING CRITICAL SUBSTRATE IN SCAR-DEPENDENT VENTRICULAR TACHYCARDIA - MICHAEL WAIGHT, LONDON, UK |
27.
ADJUNCTIVE GANGLIONATED PLEXUS ABLATION IN REDO-PULMONARY VEIN ISOLATION: THE ADD-GP STUDY - CLARE COYLE, LONDON, UK |
28.
EXPLORING CARDIAC REMODELING THROUGH ATRIAL FIBRILLATION BURDEN MONITORING USING A 72-HOUR WEARABLE ECG DEVICE AND MACHINE LEARNING METHODS - SUNGHEE SONG, SEOUL, KR |
29.
A SURVEY OF TYRX USE DURING INSERTION OF CARDIOVASCULAR IMPLANTABLE DEVICES AMONG IMPLANTERS FROM THE UNITED KINGDOM - ANDREW RAVENDREN, LONDON, UK |
30.
A RETROSPECTIVE SINGLE CENTRE REVIEW OF CARDIAC PHYSIOLOGIST LED IMPLANTABLE LOOP RECORDER (ILR) IMPLANTATION AND EXTRACTION - JAMIE MORTIBOYS, SHEFFIELD, UK |
31.
HIS BUNDLE PACING VERSUS LEFT BUNDLE BRANCH AREA PACING A COMPARATIVE STUDY OF PERIOPERATIVE OUTCOMES AT THE UNIVERSITY HOSPITALS OF LEICESTER - ABIDUR CHOWDHURY, LEICESTER, UK |
32.
RETROSPECTIVE CROSS-SECTIONAL ANALYSIS OF MICRATM LEADLESS PACEMAKER IMPLANTATION: UK TERTIARY SINGLE CENTRE EXPERIENCE FROM 2021-2024 - MAY OHN, LONDON, UK |
33.
A REGISTRY OF SUBCUTANEOUS - IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS IN A DISTRICT GENERAL HOSPITAL - PANAGIOTIS STAMATAKOS, LONDON, UK |
34.
ATRIAL FIBRILLATION DETECTION AND CHADS2-VASC2 SCORES IN POST-ISCHAEMIC STROKE PATIENTS PRESENTING WITH SINUS RHYTHM – ANALYSIS OF IMPLANTABLE ECG RECORDERS OVER A TWO YEAR PERIOD IN A LONDON TEACHING HOSPITAL - SUBRAHMANIAN MOOTHIRINGODE, LONDON, UK |
Oral Abstracts 3-Mapping and ablation
35.
HD GRID VERSUS CIRCULAR MAPPING CATHETER FOR ASSESSMENT OF PULMONARY VEIN (PV) RECONNECTIONS - KARTHICK MANOHARAN, BRIGHTON, UK |
36.
EXIT MAPPING CAN BE BETTER THAN ENTRANCE MAPPING TO IDENTIFY AND ABLATE EPICARDIAL LEFT ATRIAL CONNECTIONS - CHIROLLOS ROMANI NAGUIB, MAIDSTONE, UK |
37.
REAL-WORLD OBSERVATION STUDY OF PULSED FIELD ABLATION FOR PULMONARY VEIN ISOLATION IN A TERTIARY CENTRE IN THE UNITED KINGDOM - IVELIN KOEV, LEICESTER, UK |
38.
POST-ABLATION OUTCOMES FOR RIGHT VENTRICULAR OUTFLOW TRACT (RVOT) VENTRICULAR TACHYCARDIAS – A SINGLE CENTRE EXPERIENCE - ADITYA SHARMA, LONDON, UK |
39.
USE OF THREE-DIMENSIONAL MAPPING SYSTEMS FOR CATHETER ABLATION IN ADULTS WITH WOLFF-PARKINSON-WHITE SYNDROME - ANDREW YING, CAMBRIDGE, UK |
40.
HIGH DENSITY RIPPLE MAPPING IDENTIFIES ‘SLOW PATHWAY ACTIVATION’ ALONG THE RIGHT INFERIOR NODAL EXTENSION TO THE LOWER NODAL BUNDLE DURING AVNRT - BALRIK KAILEY, LONDON, UK |
41.
THE FEASIBILITY OF A SINGLE CATHETER APPROACH FOR PULMONARY VEIN ISOLATION USING PULSED FIELD ABLATION IN A TERTIARY CENTRE IN THE UNITED KINGDOM - IVELIN KOEV, LEICESTER, UK |
42.
IMPROVING INEQUALITIES IN HEALTH -AF SCREENING IN A RAPIDLY GROWING AT-RISK POPULATION IN NURSING HOMES IN A SURREY LOCALITY - LAUREN EMANUEL, LONDON, UK |
43.
IMPACT OF THE 2023 HEART RHYTHM SOCIETY PHYSIOLOGICAL PACING GUIDELINES AND THE BUDAPEST CRT UPGRADE STUDY - IS IT FEASIBLE TO SCREEN ALL DEVICE PATIENTS WITH ≥20% RIGHT VENTRICULAR PACING FOR PACEMAKER-INDUCED CARDIOMYOPATHY? - ADAM SIMPSON, SALFORD, UK |
44.
PROVIDING A MANDATE TO RATIONALISE FOLLOW UP IN A REGIONAL ICC BRUGADA SERVICE TO IMPROVE OUTCOMES FOR PATIENTS CLINICIANS AND SERVICE - CHARLES BOWERS, LEEDS, UK |
45.
RISK OF CARDIAC EVENTS IN OLDER ADULTS WITH ASYMPTOMATIC PRE-EXCITATION - AHMED ABOELMAATY, NEWCASTLE UPON TYNE, UK |
46.
FEASIBILITY AND SAFETY OF LEFT BUNDLE AREA PACING IN A DISTRICT GENERAL HOSPITAL - PANAGIOTIS STAMATAKOS, LONDON, UK |
47.
PREVALENCE BURDEN AND MANIFESTATION OF ATRIAL FIBRILLATION: A LARGE-SCALE ANALYSIS OF CARDIAC PATCH MONITORS - RIYAZ KABA, LONDON, UK |
48.
COMPARATIVE CLINICAL OUTCOMES IN ATRIAL FLUTTER AND ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND META-ANALYSIS - WASEEM KHAMBOO, BIRMINGHAM, UK |
49.
EXIT MAPPING FOR ACCESSORY PATHWAYS CAN FACILITATE MAPPING OF UNIDIRECTIONALLY CONDUCTING PATHWAYS - CHIROLLOS ROMANI NAGUIB, MAIDSTONE, UK |
50.
TRANSIENT CONDUCTION BLOCK DURING PULSED-FIELD ATRIAL FIBRILLATION ABLATION - MAY OHN, LONDON, UK |
51.
MOVING CLOSER TO THE TRUE RATE OF CARDIAC IMPLANTABLE ELECTRONIC DEVICE INFECTION IN GERMANY - BENITO BALDAUF, KIEL, DE |
52.
IS AI SEGMENTATION MODEL PERFORMANCE AFFECTED BY LV ANATOMICAL LOCATION? - NITHIN NARAYANAN, NOTTINGHAM, UK |
53.
THE EFFECT OF CONDUCTION SUBSTRATE ON OPTIMAL INTER-VENTRICULAR DELAY DURING LEFT BUNDLE BRANCH-OPTIMISED CARDIAC RESYNCHRONIZATION THERAPY - MARINA STROCCHI, LONDON, UK |
54.
IS THE EXERCISE COMPONENT OF SUBCUTANEOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR (SICD) SCREENING BENEFICIAL TO THE SCREENING PROCESS? - RAVEEN MALIK, LONDON, UK |
55.
A COMPARISON OF SUBCUTANEOUS AND TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN A DISTRICT GENERAL HOSPITAL- 5 YEAR EXPERIENCE - REUBEN YAP, LONDON, UK |
56.
DISPARITIES IN THE CARE AND DIRECT ORAL ANTICOAGULANT (DOAC) MANAGEMENT IN ATRIAL FIBRILLATION AND CHRONIC KIDNEY DISEASE IN ENGLISH PRIMARY CARE BETWEEN 2018-2022: PRIMARY CARE SENTINEL NETWORK DATABASE STUDY - SUBO EMANUEL, GUILDFORD, UK |
57.
THE ROLE OF GENDER IN THE EXPERIENCES, PERSPECTIVES AND CHOICES OF PEOPLE WITH ATRIAL FIBRILLATION AND HEALTH CARE PROFESSIONALS – A SCOPING REVIEW OF THE QUALITATIVE EVIDENCE - RACHEL BATES, OXFORD, UK |
58.
A NOVEL APPROACH FOR LV DELAY EVALUATION: NON-INVASIVE QLV MEASUREMENT USING UHF ECG - LUKAS POVISER, PRAGUE, CZ |
59.
WILDFIRE SMOKE CAN PRECIPITATE ATRIAL FIBRILLATION - STEVE RYAN, MALIBU, US |
60.
DOAC MANAGEMENT IN CKD AND AF WITH EMPHASIS ON INEQUALITIES IN HEALTH WITH RESPECT TO ADHERENCE AND PERSISTENCE - SUBO EMANUEL, GUILDFORD, UK |
61.
THE ROLE OF P WAVE PARAMETERS IN PREDICTING PULMONARY VEIN ISOLATION OUTCOMES FOR PAROXYSMAL ATRIAL FIBRILLATION - IBRAHIM ANTOUN, DERBY, UK |
62.
CLINICAL AUDIT OF HEART FAILURE PATIENTS TO ASSESS THE SUCCESS RATE OF LEFT VENTRICULAR RECOVERY POST GUIDELINE-DIRECTED MEDICAL THERAPY IN PATIENTS WITH MODERATE AND SEVERELY REDUCED EJECTION-FRACTION - NICOLA COOK, CAMBRIDGE, UK |
63.
THE IMPACT OF CRYOBALLOON ABLATION ON QUALITY OF LIFE IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION - TAKATOSHI SHIGETA, LONDON, UK |
64.
(WITHDRAWN) FOUR-YEAR ANALYSIS OF COMMUNITY PALPITATIONS SERVICE: DEMOGRAPHICS DIAGNOSES AND MONITORING TRENDS - MUHAMMAD MURAD KHAN, LEEDS, UK |
65.
SACUBUTRIL/VALSARTAN IN PATIENTS WITH CONGESTIVE HEART FAILURE AFTER CARDIAC RESYNCHRONIZING THERAPY - IRINA VORONTSOVA, ALMATY, KZ |
66.
CLINICAL SIGNIFICANCE OF ROUTINE PRE-DISCHARGE TESTING AFTER TRANSVENOUS DEVICE IMPLANTATIONS. A RETROSPECTIVE ANALYSIS AT A TERTIARY CENTRE - ANIKA ROSUL, LONDON, UK |
67.
COMPARATIVE SAFETY BETWEEN TRANSDIAPHRAGMATIC AND SUBXIPHOID MEDIASTINAL ACCESS MODALITY IN PATIENTS UNDERGOING HYBRID CONVERGENT ATRIAL FIBRILLATION ABLATION: A SYSTEMATIC REVIEW AND META-ANALYSIS - EDUARDO URGESI, LONDON, UK |
68.
THE IMPLICATIONS OF MISMATCHING IMPLANTABLE CARDIAC DEVICE LEAD AND CAN MANUFACTURERS AT THE ROYAL BROMPTON HOSPITAL – A CLINICAL AUDIT - NICHOLAS JONES, LONDON, UK |
69.
ENHANCING ATRIAL FIBRILLATION DETECTION: A MULTIFACETED COMPUTATIONAL APPROACH INCORPORATING HIGHER-ORDER PERFECT MATRICES OF LAGRANGE DIFFERENCES (PMLD) AND DECISION SUPPORT SYSTEM - NASEHA WAFA QAMMAR, KAUNAS, LI |
70.
OUTCOMES FROM CONSULTANT-LED CARDIAC IMPLANTABLE DEVICES TROUBLESHOOTING CLINIC AT A TERTIARY CARDIAC CENTRE - KHALID RASHID, MIDDLESBROUGH, UK |
71.
EMBEDDING INNOVATIONS IN CLINICAL TRIALS INTO ROUTINE HEALTHCARE – INSIGHTS FROM THE DARE2THINK TRIAL - NAFEESAH HAIDER, BIRMINGHAM, UK |
72.
TOLERABILITY AND SIDE EFFECT PROFILE OF AMIODARONE IN CARDIOLOGY OUTPATIENTS: A STUDY OF 150 PATIENTS - KHALID ALGHARBEH, AYLESBURY, UK |
73.
ESTABLISHING A SPECIALIST ATRIAL FIBRILLATION CLINIC LED BY ARRHYTHMIA NURSES - GAVIN KELLY, THORNTON HEATH, UK |
74.
THE USE OF THE ALIVECOR KARDIAMOBILE DEVICE OUTPERFORMS STANDARD MONITORING IN THE INVESTIGATION OF SYMPTOMATIC ARRHYTHMIA - ATMADEEP BANERJEE, CHICHESTER, UK |
75.
STROKE PROPHYLAXIS IN ATRIAL FIBRILLATION AND CONCOMITANT MITRAL STENOSIS: AN EVALUATION OF CHOICE OF ORAL ANTICOAGULANT - ROWAN HALL, LEEDS, UK |
76.
A GENDER-BASED COMPARATIVE ANALYSIS OF CLINICAL OUTCOMES OF CONDUCTION SYSTEM PACING AS AN ABLATE AND PACE STRATEGY IN ATRIAL FIBRILLATION MANAGEMENT FOR HEART FAILURE PATIENTS: A TERTIARY CENTRE EXPERIENCE - AHMED ABDELRAZIK, LEICESTER, UK |
77.
EFFICACY OF DC CARDIOVERSION IN PATIENTS WITH HEART FAILURE AND ATRIAL FIBRILLATION - HAMMAD LAKHANI, BIRMINGHAM, UK |
78.
EFFECTIVENESS OF A TWO-WEEK HOLTER LOOP RECORDER AS A DIAGNOSTIC REMOTE SCREENING TOOL FOR ATRIAL FIBRILLATION IN POST-STROKE PATIENTS DURING COVID-19 PANDEMIC ERA IN A TERTIARY CARE HOSPITAL - KHIN KAY KAY KYAW, TORBAY, UK |
79.
EXPLORING DIET-BASED TREATMENTS FOR ATRIAL FIBRILLATION: PATIENT EMPOWERMENT AND CITIZEN SCIENCE AS A MODEL FOR QUALITY OF LIFE-CENTERED SOLUTIONS - MYRTHE KUIPERS, AMSTERDAM, NL |
80.
MILTON KEYNES HEART TEAM ARRHYTHMIA ALLIANCE-PACE4LIFE: CHARITY MISSIONS TO INDIA - IRFAN KAZI, MILTON KEYNES, UK |
81.
A COMPREHENSIVE "ICD SHOCKS" APPROACH TO MANAGE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) SHOCK PATIENTS - MAY OHN, LONDON, UK |
82.
OUTCOMES OF CONCURRENT THORACOSCOPIC EPICARDIAL LEFT ATRIAL APPENDAGE CLIPPING WITH CONVERGENT HYBRID ATRIAL FIBRILLATION ABLATION - LEFT VENTRICULAR SYSTOLIC DYSFUNCTION APPEARS A MARKER FOR INCREASED OPERATIVE RISK - OMAR AHMED, LONDON, UK |
83.
DIGOXIN TOXICITY IN ENTEROVIRAL MYOCARDITIS - A CASE SERIES - MUTHUKUMARA RAVICHANDRAN, CARDIFF, UK |
84.
KCNQ1 MUTATION PRESENTING WITH COMPLETE HEART BLOCK (CHB) AND LONG QT SYNDROME (LQTS) - GAURI NEPALI, BIRMINGHAM, UK |
85.
PAEDIATRIC RADIOFREQUENCY ABLATION OF A LEFT ANTERIOR ACCESSORY PATHWAY IN PATIENT WITH COMPLEX ANATOMY USING THE TRANSHEPATIC VENOUS APPROACH - CAMILLE MARIE GO-CACANINDIN, BIRMINGHAM, UK |
86.
THE CASE WHICH GAVE ME CHEST PAIN - NADEZHDA DZHELEPOVA, MANCHESTER, UK |